DXCM vs RYAM · P/E 63, rev $2.50B vs rev $695.2M
DexCom Inc (DXCM) versus Rayonier Advanced Materials (RYAM) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Rayonier Advanced Materials (RYAM) is a chemicals company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported RYAM revenue for 2026-06-27 was $695.2M. Net income was -$114.4M. RYAM currently screens at market cap $242.4M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. RYAM currently screens at market cap $242.4M.
Not investment advice. Open the DXCM and RYAM stock pages for the full models.
Not investment advice.